NVO241122C85000
- 0.00
- 0.000.00%
Novo-Nordisk A/S Newsroom
Novo Nordisk (NVO) Among the Most Profitable Pharmaceutical Stocks Right Now
10 Health Care Stocks With Whale Alerts In Today's Session
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Novo Nordisk's Experimental Obesity Drug CagriSema Sales Forecast Overly Optimistic -- Market Talk
Novo Nordisk's Sales Growth at Risk Over U.S. Price Erosion -- Market Talk
Why Is Novo Nordisk A/S (NVO) Among Louis Navellier's Top Stock Picks Heading Into 2025?
Novo Nordisk A/S (NVO): A Bull Case Theory
What the Options Market Tells Us About Novo Nordisk
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.
On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.
Sector Update: Health Care Stocks Advance Wednesday Afternoon
LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs
Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight
Express News | Novo Nordisk Says Health Canada Approves Wegovy (Semaglutide Injection) To Reduce Risk Of Non-Fatal Myocardial Infarction
Will weight loss drugs be included in the US medical insurance, becoming the strongest "roadblock" for the Trump team?
The "Dual Weight Loss Champions" led the significant rise.
Health Care Up as Ely Lilly Rallies on Medicare Proposal -- Health Care Roundup
U.S. stocks closed: The Dow and S&P reached all-time highs, while general motors plunged nearly 9%.
① Most technology giants rose, only Tesla fell; ② Eli Lilly and Co rose by 4.5%, as Biden proposed health insurance coverage for weight loss drugs; ③ The Chinese concept stock Jinlong Index fell by 0.8%, Nio fell by 7.7%; ④ Apple proposed to increase investment by 0.1 billion US dollars to seek to lift the sales ban, but was rejected by the Indonesian government.
Novo and Lilly Surge as Amgen Stumbles in Competitive Weight-Loss Market
European Equities Close Lower in Tuesday Trading